Unilife Corporation To Announce Financial Results For Fiscal 2013 Second Quarter On Monday, February 11, 2013

   Unilife Corporation To Announce Financial Results For Fiscal 2013 Second
                     Quarter On Monday, February 11, 2013

Schedules Conference Call for 4:30 p.m. EST on Monday, February 11, 2013

PR Newswire

YORK, Pa., Feb. 6, 2013

YORK, Pa., Feb. 6, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or
"Company") (NASDAQ: UNIS;  ASX: UNS) announced today that it intends to
release its financial results for the fiscal 2013 second quarter ended
December 31, 2012 after market trading ends on Monday, February 11, 2013.

Management has scheduled a conference call for 4:30 p.m. U.S. EST on Monday,
February 11, 2013 (Tuesday, February 12, 2013 at 8:30 a.m.  AEDT), to review
the Company's financial results, market trends, and future outlook.  The
conference call will be broadcast over the Internet as a "live" listen only
Webcast. To listen, please go to: http://ir.unilife.com/events.cfm. Listeners
are urged to login approximately 20 minutes before the conference call is
scheduled to begin in order to register, as well as download and install any
necessary audio software. An archive of the webcast will be available on the
Company's website.

About Unilife Corporation

Unilife Corporation (NASDAQ:UNIS / ASX: UNS) is a U.S. based developer and
commercial supplier of advanced drug delivery systems. Unilife collaborates
with pharmaceutical and biotechnology companies seeking innovative,
differentiated devices that can enable or enhance the delivery of injectable
drugs and vaccines supplied in either a liquid stable or lyophilized form. The
Unifill syringe, the world's first and only prefilled syringe with fully
integrated safety features, sits at the leading edge of this diversified
portfolio. In addition to prefilled and hypodermic safety syringes with
automatic, user-controlled needle retraction, Unilife has other proprietary
technology platforms including drug reconstitution delivery systems,
auto-injectors, auto-infusion pump systems and specialized devices for
targeted organ delivery. Unilife's global headquarters and state-of-the-art
manufacturing facilities are located in York, PA. For more information on
Unilife, please visit www.unilife.com.   

Forward-Looking Statements

This press release contains forward-looking statements. All statements that
address operating performance, events or developments that we expect or
anticipate will occur in the future are forward-looking statements. These
forward-looking statements are based on management's beliefs and assumptions
and on information currently available to our management. Our management
believes that these forward-looking statements are reasonable as and when
made. However, you should not place undue reliance on any such forward-looking
statements because such statements speak only as of the date when made. We do
not undertake any obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events or
otherwise, except as required by law. In addition, forward-looking statements
are subject to certain risks and uncertainties that could cause actual
results, events and developments to differ materially from our historical
experience and our present expectations or projections. These risks and
uncertainties include, but are not limited to, those described in "Item 1A.
Risk Factors" and elsewhere in our Annual Report on Form 10-K and those
described from time to time in other reports which we file with the Securities
and Exchange Commission. 

General: UNIS-G

Investor Contacts (US):                 Analyst              Investor Contacts
                                        Enquiries            (Australia)
Todd Fromer / Garth Russell             Lynn Pieper          Jeff Carter
               
KCSA Strategic                          Westwicke Partners   Unilife
Communications                                               Corporation
P: + 1 212-896-1215 / 212-896-1250      P: + 1               P: + 61 2 8346
                                        415-202-5678         6500

SOURCE Unilife Corporation

Website: http://www.unilife.com